Key Highlights

  • Lifeway Foods shares dipped 4.3% in extended trading on November 12, 2026, following the release of third-quarter results.
  • Net sales reached a record USD 67.8 million, climbing 18.6%, yet gross Margin contracted to 18.0% from 28.7% amid higher input and freight costs.
  • Net income landed at USD 0.3 million, or USD 0.02 per share, against USD 3.5 million, or USD 0.23 per share, twelve months earlier.
  • Management says it is tracking toward record 2026 sales and anticipates price rises plus a Facility expansion to rebuild margins in 2027.

Higher Volume Meets Shrinking Profit

Lifeway Foods (NASDAQ:LWAY) moved more units in the quarter but kept far less profit on each one. Net sales of USD 67.8 million grew 18.6% on bigger volumes of drinkable kefir, and nine-month Revenue reached USD 197.7 million, a 25.8% gain. The kefir category leader called the period another record. Profitability told a different story: gross margin slid to 18.0% from 28.7%, Operating Income declined from USD 5.040 million to USD 1.085 million, and Net Income came in at USD 0.3 million, or USD 0.02 per share, under the estimate. Management pointed to elevated input costs, including higher freight charges, and expects the squeeze to persist into the fourth quarter. Selling and administrative expenses eased to 16.2% of sales from 19.6%, softening the operating decline without replacing the lost gross profit. The after-hours drop of 4.3% looks mild next to the size of the Earnings shortfall.

Plant Spending Strains Cash Generation

Growth has come with heavy outlays. Capital Expenditure over nine months reached USD 22.8 million, compared with USD 9.7 million a year earlier, as Lifeway Foods (NASDAQ:LWAY) expands production capacity, and the Waukesha facility upgrade is scheduled for completion in early 2027. Operating Cash Flow across the first nine months dropped to USD 4.9 million from USD 10.7 million. Borrowing has funded part of it, through a Credit line of USD 11.95 million and a USD 12.0 million note payable added since 2025 closed, while cash climbed to USD 6.975 million. The buildout explains how volume can rise at double-digit rates, and it also explains why Debt costs now carry more weight in earnings. If input costs stay elevated, the new plant could drag on returns for longer than planned, which makes the timing of margin recovery the central question for the Investment case.

Pricing Power and Execution Risks

Price increases are set to roll out through year-end and into the first quarter of 2027. Management said its 2027 outlook is unchanged, still calling for gross margin expansion and better profitability. Whether that works depends on shoppers accepting higher prices in a segment where store brands and rival labels fight for shelf space. Kefir has gained from interest in gut health and high-protein foods, and Lifeway's category Leadership supports its pricing power. Other risks include milk cost swings, freight charges, pushback from retailers and possible delays at the new site. Investors in Lifeway Foods (NASDAQ:LWAY) will track fourth-quarter gross margin, the prices realized on shelves, debt levels and when the plant is finished. Sales momentum is not in question; the real test is how quickly margin climbs back toward the high-twenties, a level that would restore earnings to last year's.

Where Things Stand

Lifeway Foods (NASDAQ:LWAY) shed 4.3% in extended trading, after record third-quarter sales of USD 67.8 million were paired with an 18.0% gross margin and net income of just USD 0.02 per share. Higher prices through early 2027, along with a larger plant, are designed to rebuild profit. Relief on input costs, borrowing expenses and customer acceptance of higher prices will set the pace of that recovery.